[

remdesivir

]
PAGE 3

Covid-19: Gujarat government orders 3 lakh Remdesivir injections

"My government has placed an order to procure 3 lakh Remdesivir injections from a Gujarat-based pharma company, which has already started supplying around 20,000 injections every day," chief minister Vijay Rupani said.
Chief Minister Vijay Rupani address a press meet on the surge of COVID-19 cases, in Gandhinagar on Thursday. (ANI Photo)
Chief Minister Vijay Rupani address a press meet on the surge of COVID-19 cases, in Gandhinagar on Thursday. (ANI Photo)
Published on Apr 06, 2021 08:08 PM IST
Copy Link
PTI | , Surat

Rajasthan governement supplies 10,000 doses of Remdesivir injection to Punjab

After flagging off a vehicle carrying the doses from his residence this afternoon, Rajasthan Health Minister Raghu Sharma said the injections have been provided to Punjab free of cost.
Rajasthan health minister Raghu Sharma said that hundreds of lives have been saved due to a timely availability of this costly injection.(Twitter/@RaghusharmaINC)
Rajasthan health minister Raghu Sharma said that hundreds of lives have been saved due to a timely availability of this costly injection.(Twitter/@RaghusharmaINC)
Published on Mar 22, 2021 11:08 PM IST
Copy Link
PTI | , Jaipur

Remdesivir may be highly effective against coronavirus, case study finds

The researchers suspect that remdesvir is likely to be most beneficial when administered early in infection, before the virus is able to trigger a potentially catastrophic immune response.
An ampule of remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease continues.(REUTERS)
An ampule of remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease continues.(REUTERS)
Updated on Dec 14, 2020 06:55 PM IST
Copy Link
London | By Press Trust of India | Posted by Arpan Rai

EU drug regulator endorses changes to remdesivir marketing for Covid-19 use

The new terms of the conditional marketing authorisation in Europe add that a patient could need “low- or high-flow oxygen or other non-invasive ventilation at start of treatment,” according to the European Medicines Agency
Europe’s drugs regulator on Friday recommended changing some terms of the conditional approval given to antiviral drug remdesivir as a Covid-19 treatment(REUTERS)
Europe’s drugs regulator on Friday recommended changing some terms of the conditional approval given to antiviral drug remdesivir as a Covid-19 treatment(REUTERS)
Published on Dec 11, 2020 07:05 PM IST
Copy Link
Brussels | By Reuters | Posted by Ayshee Bhaduri

WHO advises against Gilead’s Remdesivir for all hospitalised Covid-19 patients

The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for Covid-19 in the summer after early trials showed some promise.
Two ampules of Ebola drug Remdesivir are pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany.(Reuters File Photo)
Two ampules of Ebola drug Remdesivir are pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany.(Reuters File Photo)
Updated on Nov 20, 2020 05:48 AM IST
Copy Link
London | By Reuters | Posted by Kanishka Sarkar

Covid-19: Gilead’s Remdesivir is first virus drug to get FDA approval

Regulators had granted an emergency-use authorization for remdesivir earlier this year, and since then the drug has become a widely used therapy in hospitalized Covid-19 patients. It was given to President Donald Trump this month when he was diagnosed with the virus.
A bottle containing the drug Remdesivir is shown by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary.(AP)
A bottle containing the drug Remdesivir is shown by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary.(AP)
Updated on Oct 23, 2020 04:22 AM IST
Copy Link
By Bloomberg | Posted by Shivani Kumar

From HCQ to remdesivir, the treatment options for Covid-19

Covid-19 treatment: There are several, and which one is best depends on how sick someone is.
A police officer wearing a protective mask looks on, amid the outbreak of the coronavirus disease, in Manchester, Britain.(REUTERS)
A police officer wearing a protective mask looks on, amid the outbreak of the coronavirus disease, in Manchester, Britain.(REUTERS)
Published on Oct 20, 2020 04:18 PM IST
Copy Link
Associated Press | By Associated Press | Posted by Arpan Rai

EU has agreed supply of 20,000 additional doses of Remdesivir

A spokesman for the EU executive said Brussels had agreed with Gilead last Friday the supply of nearly 20,300 additional doses for the treatment of about 3,400 patients.
A lab technicians holds the coronavirus disease (Covid-19) treatment drug
A lab technicians holds the coronavirus disease (Covid-19) treatment drug "Remdesivir".(Reuters)
Updated on Oct 07, 2020 05:14 PM IST
Copy Link
By Reuters | Posted by Shivani Kumar

77% treated with Remdesivir, Tocilizumab survived: Data

Remdesivir is an antiviral drug used for treatment of Ebola which costs 5,000 per vial. It is manufactured by Hyderabad-based Hetero Healthcare and Cipla.
A vendor sharpens a knife while sitting on his bicycle as people wearing protective face masks move past him in a market, amidst the spread of the coronavirus disease in Mumbai, India.(REUTERS)
A vendor sharpens a knife while sitting on his bicycle as people wearing protective face masks move past him in a market, amidst the spread of the coronavirus disease in Mumbai, India.(REUTERS)
Updated on Aug 27, 2020 01:44 AM IST
Copy Link
Hindustan Times, Mumbai | By Rupsa Chakraborty

Covid-19: 3 Indian companies start supply of life-saving Remdesivir to Nepal

Remdesivir has been proved to be efficient for patients who have been put in the Intensive Care Unit and take them out of danger zone but wasn’t available in the Himalayan nation.
More than half of 123 companies permitted to import medicines from other nations are Indian companies who work on various forms for parent companies headquartered in Europe or America(Reuters)
More than half of 123 companies permitted to import medicines from other nations are Indian companies who work on various forms for parent companies headquartered in Europe or America(Reuters)
Updated on Aug 21, 2020 05:12 PM IST
Copy Link
By Asian News International | Posted by Shivani Kumar

21 existing drugs identified that block Covid-19 causing coronavirus in lab studies

According to the study, published in the journal Nature, 21 of these drugs are effective in blocking the reproduction of the coronavirus at concentrations that could be safely achieved in patients.
FILE PHOTO: An ampule of Remdesivir. According to a study published in the journal Nature, four of the compounds could work in combination with remdesivir, a current standard-of-care treatment for Covid-19.(REUTERS File)
FILE PHOTO: An ampule of Remdesivir. According to a study published in the journal Nature, four of the compounds could work in combination with remdesivir, a current standard-of-care treatment for Covid-19.(REUTERS File)
Updated on Jul 25, 2020 02:22 PM IST
Copy Link
Los Angeles | By Press Trust of India | Posted by Anubha Rohatgi

Mylan launches Remdesivir’s generic version ‘Desrem’ in India for Covid-19 patients

Mylan will manufacture Desrem in its injectable facility in Bengaluru, which will work to service the demand in India and other export markets where Mylan has received a licence from Gilead for the commercialisation of Remdesivir, a company statement said.
File photo of an ampule of the drug Remdesivir . Pharamaceutical firm Mylan has launched the generic version of Remdesivir in India at a price of Rs 4,800 per 100 mg.(REUTERS File Photo)
File photo of an ampule of the drug Remdesivir . Pharamaceutical firm Mylan has launched the generic version of Remdesivir in India at a price of Rs 4,800 per 100 mg.(REUTERS File Photo)
Updated on Jul 20, 2020 02:54 PM IST
Copy Link
New Delhi | By Press Trust of India | Posted by Anubha Rohatgi

Covid-19 vaccine update: Latest on Gilead’s remdesivir, Moderna’s experimental candidate and others

According to the World Health Organization, there are 23 candidate vaccines in the clinical evaluation phase while 140 candidate vaccines are currently in the preclinical evaluation phase.
Gilead Sciences Inc’s remdesivir is at the forefront of the efforts to treat the disease after it helped shorten hospital recovery times in a clinical trial.(AFP)
Gilead Sciences Inc’s remdesivir is at the forefront of the efforts to treat the disease after it helped shorten hospital recovery times in a clinical trial.(AFP)
Updated on Jul 15, 2020 08:46 AM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Sparshita Saxena

IMA opposes move to make Covid-19 report must to buy remdesivir and tocilizumab

Members of IMA said every day Maharashtra requires almost 1.5 lakh vials of remdesivir and that hospitals across the state are facing an acute shortage of the two drugs.
Due to the sudden rise in demand for these drugs, suppliers are selling them to highest bidders, said IMA.(Sunil Ghosh / Hindustan Times)
Due to the sudden rise in demand for these drugs, suppliers are selling them to highest bidders, said IMA.(Sunil Ghosh / Hindustan Times)
Updated on Jul 14, 2020 08:51 AM IST
Copy Link
Hindustan Times, Mumbai | By Rupsa Chakraborty, Mumbai

One in three South Korean Covid-19 patients showed improvement with remdesivir: Officials

Several countries including South Korea have added the drug to the list of treatment for the disease caused by the novel coronavirus. There is no approved vaccine for it.
Remdesivir has been at the forefront of the global battle against Covid-19 after the intravenously administered medicine helped shorten hospital recovery times in a U.S. clinical trial.(Reuters File)
Remdesivir has been at the forefront of the global battle against Covid-19 after the intravenously administered medicine helped shorten hospital recovery times in a U.S. clinical trial.(Reuters File)
Updated on Jul 14, 2020 12:39 AM IST
Copy Link
Seoul | By Reuters | Posted by Anubha Rohatgi

Gilead says additional data on remdesivir shows improved clinical recovery

Gilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity as in the study.
An ampule of Ebola drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany.(Reuters file photo)
An ampule of Ebola drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany.(Reuters file photo)
Updated on Jul 10, 2020 07:16 PM IST
Copy Link
By Reuters | Posted by Shivani Kumar

Mylan to launch generic version of Covid-19 treatment drug remdesivir in India this month

The Drug Controller General of India (DCGI) approved Mylan’s remdesivir version, to be called Desrem, for the treatment of suspected or laboratory confirmed severe incidences of Covid-19 in adults and children, the company said in a statement.
Remdesivir is in high demand after the intravenously-administered medicine helped to shorten hospital recovery times in a clinical trial. On Friday, it got conditional approval from the European Commission for use in severe Covid-19 patients.(REUTERS File Photo)
Remdesivir is in high demand after the intravenously-administered medicine helped to shorten hospital recovery times in a clinical trial. On Friday, it got conditional approval from the European Commission for use in severe Covid-19 patients.(REUTERS File Photo)
Updated on Jul 06, 2020 05:04 PM IST
Copy Link
Bengaluru | By Reuters | Posted by Anubha Rohatgi

News updates from Hindustan Times: Remdesivir dosage revised, now to be taken for five days and all the latest news

Here are today’s top news, analysis and opinion. Know all about the latest news and other news updates from Hindustan Times.
A lab technician loads bright stock filled vials of investigational coronavirus disease (COVID-19) treatment drug remdesivir.(Reuters)
A lab technician loads bright stock filled vials of investigational coronavirus disease (COVID-19) treatment drug remdesivir.(Reuters)
Updated on Jul 04, 2020 09:05 AM IST
Copy Link
Hindustan Times, New Delhi | By HT Correspondent

Remdesivir dosage revised, now to be taken for five days

The loading dose of 200 mg (shot) on day 1, will now be followed by 100 mg (shot) daily for 4 days (total 5 days). Earlier, the follow up dose was for 5 days.
Remdesivir was allowed by the drugs controller of India under emergency use authorization for Covid-19 patients.(Reuters file photo)
Remdesivir was allowed by the drugs controller of India under emergency use authorization for Covid-19 patients.(Reuters file photo)
Published on Jul 04, 2020 08:15 AM IST
Copy Link
Hindustan Times, New Delhi | By HT Correspondent

Gilead prices Covid-19 drug candidate remdesivir at $2,340 per patient

The price tag is below the $5,080 per course recommendation by U.S. drug pricing research group, the Institute for Clinical and Economic Review (ICER), last week.
Gilead Sciences Inc has priced its Covid-19 drug candidate remdesivir at $2,340 for a five-day treatment in the United States and some other developed countries, potentially reflecting looming competition from a cheap steroid.(File photo for representation)
Gilead Sciences Inc has priced its Covid-19 drug candidate remdesivir at $2,340 for a five-day treatment in the United States and some other developed countries, potentially reflecting looming competition from a cheap steroid.(File photo for representation)
Updated on Jun 29, 2020 07:53 PM IST
Copy Link
By Reuters | Posted by Niyati Singh

South Korea backs remdesivir for Covid-19, urges caution with dexamethasone

South Korea’s updated guidelines come after a study showed that the cheap and widely used dexamethasone reduced deaths in very sick Covid-19 patients. They advised doctors to take caution until a full study is published.
Remdesivir is designed to hinder certain viruses, including the new coronavirus, from making copies of themselves and potentially overwhelming the body’s immune system.(REUTERS)
Remdesivir is designed to hinder certain viruses, including the new coronavirus, from making copies of themselves and potentially overwhelming the body’s immune system.(REUTERS)
Updated on Jun 26, 2020 06:34 PM IST
Copy Link
Seoul | By Reuters | Posted by Jasra Afreen

European regulator recommends remdesivir for Covid-19 treatment

The European healthcare regulator has recommended the conditional approval of Gilead Sciences Inc’s antiviral treatment, remdesivir, for use in Covid-19 patients, making it the first treatment to be on track to be green-lit in the continent.
The price of the drug in the region is not yet known. In the United States, it could be priced up to $5,080 per course, while Indian generic drugmakers will sell the treatment between 5,000 rupees to 6,000 rupees ($66.13-$79.35).(File photo for representation)
The price of the drug in the region is not yet known. In the United States, it could be priced up to $5,080 per course, while Indian generic drugmakers will sell the treatment between 5,000 rupees to 6,000 rupees ($66.13-$79.35).(File photo for representation)
Updated on Jun 26, 2020 04:24 AM IST
Copy Link
By Reuters | Posted by Niyati Singh

India’s Hetero prices generic remdesivir for Covid-19 treatment at Rs5,400 per vial

India has approved the generic versions made by Cipla and Hetero for restricted emergency use in severe Covid-19 cases.
An ampule of Ebola drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany as the spread of coronavirus disease (Covid-19) continues.(Reuters File Photo)
An ampule of Ebola drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany as the spread of coronavirus disease (Covid-19) continues.(Reuters File Photo)
Updated on Jun 25, 2020 01:11 PM IST
Copy Link
Bengaluru | By Reuters | Posted by Kanishka Sarkar

Covid-19 updates: South Africa begins first trials for Covid-19 vaccine

The first clinical trial of Covid-19 vaccine developed by the Oxford University has begun in South Africa.
FILE PHOTO: Phials of an mRNA type vaccine candidate for the coronavirus disease (Covid-19) are pictured at Chulalongkorn University during the development of an mRNA type vaccine in Bangkok, Thailand.(REUTERS)
FILE PHOTO: Phials of an mRNA type vaccine candidate for the coronavirus disease (Covid-19) are pictured at Chulalongkorn University during the development of an mRNA type vaccine in Bangkok, Thailand.(REUTERS)
Updated on Jun 25, 2020 10:42 AM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Sparshita Saxena

From Chinese anti-Covid-19 shots, latest on remdesivir to Patanjali’s coronavirus drugs: Top updates

With 15,968 fresh cases in the last 24 hours, India’s Covid-19 tally went up to 456,183 on Wednesday.
File photo: Small bottles labeled with a
File photo: Small bottles labeled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration.(REUTERS)
Updated on Jun 24, 2020 11:02 AM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Sparshita Saxena

Covid-19: Trials for inhaled version of remdesivir to start in August

Gilead Sciences has said it will soon start clinical trials for inhaled formulation of its antiviral drug remdesivir used for the treatment of Covid-19. The US drugmaker said the trials will begin in August.
The totality of these data shows that remdesivir has the potential to be of meaningful benefit to patients with Covid-19.(Reuters file photo)
The totality of these data shows that remdesivir has the potential to be of meaningful benefit to patients with Covid-19.(Reuters file photo)
Updated on Jun 24, 2020 05:50 AM IST
Copy Link
livemint, New Delhi | By Neetu Chandra Sharma

Maharashtra: High case fatality rate remains a cause for concern for state authorities

The CFR in Maharashtra has risen over the past few weeks, up from 3.25% on May 25 and 3.37% on May 31, when the state government had vowed to bring it down to below 3%.
Maharashtra’s cumulative number of Covid-19 cases on Sunday evening stood at 132,07 and the death toll touched 6,170.(HT photo)
Maharashtra’s cumulative number of Covid-19 cases on Sunday evening stood at 132,07 and the death toll touched 6,170.(HT photo)
Updated on Jun 22, 2020 12:13 PM IST
Copy Link
Hindustan Times, Mumbai | By Surendra P Gangan

Domestic pharma giants-- Cipla, Hetero got DCGI’s nod to manufacture, sell anti-viral Remdesivir drug to fight Covid-19

With this development, India is soon to begin the domestic production of anti-viral drug remdesivir which would have efficacy, stability, safety for “restricted emergency use” on Covid-19 patients, official added.
Gilead had signed non-exclusive voluntary licensing agreements with five generic pharma firms -- Cipla, Jubilant Life Sciences, Hetero, BRD and Mylan to manufacture and distribute remdesivir, a potential antiviral therapy for Covid-19.(Reuters)
Gilead had signed non-exclusive voluntary licensing agreements with five generic pharma firms -- Cipla, Jubilant Life Sciences, Hetero, BRD and Mylan to manufacture and distribute remdesivir, a potential antiviral therapy for Covid-19.(Reuters)
Published on Jun 21, 2020 09:11 AM IST
Copy Link
New Delhi, India | By Asian News International | Posted by: Shivani Kumar

Covid-19 vaccine update: Russia begins clinical trials, Gilead to enrol pediatric patients in remdesivir testing

From experimental drug remdesivir making strides to generic steroid drug dexamethasone emerging as the first Covid-19 drug, the race to developing the antidote to Covid-19 is getting more interesting by the day.
File photo: A researcher at Protein Sciences reaches for a vial in a lab in Meriden, Conn. The biotech company is currently researching a vaccine for Covid-19.(AP)
File photo: A researcher at Protein Sciences reaches for a vial in a lab in Meriden, Conn. The biotech company is currently researching a vaccine for Covid-19.(AP)
Updated on Jun 18, 2020 12:49 PM IST
Copy Link
Hindustan Times, New Delhio | By hindustantimes.com | Edited by Sparshita Saxena

Remdesivir, now part of Covid-19 therapy in Centre’s new health protocol document

In the new set of protocols, the ministry has removed its earlier recommendation of using hydroxychloroquine in combination with azithromycin in severe cases and requiring ICU management.
Vials of investigational Covid-19 treatment drug Remdesivir being capped at a Gilead Sciences facility in California in the United States.(REUTERS PHOTO.)
Vials of investigational Covid-19 treatment drug Remdesivir being capped at a Gilead Sciences facility in California in the United States.(REUTERS PHOTO.)
Updated on Jun 14, 2020 05:32 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Sohini Sarkar
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
×
Saved Articles
My Reads
Sign out
New Delhi 0C
Saturday, October 16, 2021